# Communicating Uncertainties Associated With the Benefits and Risks of New Cancer Drugs

> **NCT06997185** · NA · RECRUITING · sponsor: **London School of Economics and Political Science** · enrollment: 3000 (estimated)

## Conditions studied

- Cancer

## Interventions

- **OTHER:** Statement communicating uncertainty with a single arm trial
- **OTHER:** Statement communicating uncertainty with limited study duration
- **OTHER:** Statement communicating uncertainty with a limited study population
- **OTHER:** Statement communicating uncertainty with an unvalidated surrogate endpoint
- **OTHER:** Statement communicating uncertainty with treatment effect size

## Key facts

- **NCT ID:** NCT06997185
- **Lead sponsor:** London School of Economics and Political Science
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-09
- **Primary completion:** 2025-06
- **Final completion:** 2025-06
- **Target enrollment:** 3000 (ESTIMATED)
- **Last updated:** 2025-05-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06997185

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06997185, "Communicating Uncertainties Associated With the Benefits and Risks of New Cancer Drugs". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06997185. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*